Characterizing the role of LXRα pS196 in hematopoietic cells and their contribution to atherosclerosis and obesity has the potential to reveal new therapeutic strategies for both pathologies. Here, NR1H3 is linked to obesity due to melanocortin 4 receptor deficiency.